- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Canine CA199 antibody and antigen (recombinant protein)
Diagnostic anti-Canine CA199 antibodies pairs and antigen for animal health (animal Dog/Canine pancreatic and biliary tract tumors) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Companion Animal disease testing products collection >>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-CAN-CA199-Ag01 | Canine CA199 | $3090.00 |
| GMP-CAN-CA199-Ab01 | Anti-Canine CA199 mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-CAN-CA199-Ab02 | Anti-Canine CA199 mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-CAN-CA199-Ab03 | Anti-Canine CA199 human monoclonal antibody (mAb) | $3090.00 |
| GMP-CAN-CA199-Ab04 | Anti-Canine CA199 human monoclonal antibody (mAb) | $3090.00 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. | GMP-CAN-CA199-Ag01 |
| Product Name | Canine CA199 |
| Target/Biomarker | Canine CA199 |
| Expression platform | E.coli |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | Anti-Canine CA199 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA199 level test of animal Dog/Canine with pancreatic and biliary tract tumors. |
| Tag | His | Reconized/Reactive Specics | Canine CA199 |
| Product description | Recombinant Canine CA199 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-CAN-CA199-Ab01,GMP-CAN-CA199-Ab02 |
| Target/Biomarker | Canine CA199 |
| Product Name | Anti-Canine CA199 mouse monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Recombinant Canine CA199 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine CA199 antibodies in Canine CA199 level test of animal Dog/Canine with pancreatic and biliary tract tumors. |
| Product description | Anti-Canine CA199 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine CA199 antibodies. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-CAN-CA199-Ab03,GMP-CAN-CA199-Ab04 |
| Target/Biomarker | Canine CA199 |
| Product Name | Anti-Canine CA199 human monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Human lgG1 |
| Bioactivity validation | Recombinant Canine CA199 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine CA199 antibodies in Canine CA199 level test of animal Dog/Canine with pancreatic and biliary tract tumors. |
| Product description | Anti-Canine CA199 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
Cancer Antigen 199 (CA199) is a glycoprotein biomarker with vital implications in the realm of canine health. This biomarker is primarily associated with the diagnosis and monitoring of cancer in dogs (canines), particularly cancers affecting the pancreas and gastrointestinal tract. CA199 stands out due to its unique structure, characterized by a protein core to which carbohydrate molecules are attached.
In the context of canine health, CA199 is a key player in the identification of cancer. When cancer cells, especially those found in pancreatic and gastrointestinal cancers, proliferate within a dog's body, they produce and release CA199 into the bloodstream. This glycoprotein can be detected through blood tests, offering a non-invasive means of diagnosing and monitoring these types of cancer.
CA199 is not exclusive to cancer diagnosis; it also has value in assessing the response to cancer treatment in dogs. Monitoring changes in CA199 levels over time can provide critical insights into the effectiveness of therapeutic interventions. This dynamic approach enables veterinarians to tailor treatment strategies to individual canine patients, optimizing their care and enhancing their overall well-being.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
